Special Issue "Prostate Cancer: Current Strategies and Emerging Approaches"

A special issue of Uro (ISSN 2673-4397).

Deadline for manuscript submissions: 30 November 2023 | Viewed by 105

Special Issue Editors

Dr. El Din Tantawy Emiliano Salah
E-Mail Website
Guest Editor
Department of Radiation Oncology, Azienda Ospedaliera Universitaria Integrata di Verona, 37126 Verona, Italy
Interests: radiation oncology; breast cancer; prostate cancer; urogenital cancer; genitourinary cancer
Department of Radiotherapy, Verona University Hospital, Piazzale A. Stefani, 1-37126 Verona, Italy
Interests: external beam radiation therapy; intraoperative radiation therapy; pancreatic cancer; breast cancer; brain cancer; prostate cancer; stereotactic body radiation therapy (SBRT)
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Prostate cancer is one of the most common types of cancer in men worldwide. Despite significant advancements in diagnosis and treatment, prostate cancer still poses a significant health threat to men. Therefore, continued research and innovation are necessary to improve patient outcomes and quality of life. Despite significant progress in the diagnosis and treatment of prostate cancers, many aspects of these diseases still present challenges for clinicians and researchers. This Special Issue of Uro will explore a range of topics related to prostate cancers, including cutting-edge research on advanced imaging techniques, molecular characterization, current and emerging treatment options, and patient-centered care. We invite original research articles, expert opinions, systematic reviews, and meta-analyses that contribute to a deeper understanding of these complex diseases and offer innovative approaches to improving patient outcomes and quality of life. In this Special Issue, we aim to highlight the latest advancements in the treatment of prostate cancer, as well as discuss the future directions in the field.

Dr. El Din Tantawy Emiliano Salah
Dr. Renzo Mazzarotto
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Uro is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • prostate cancer
  • surgery
  • radiation therapy
  • hormonal therapy
  • immunotherapy
  • targeted therapy
  • precision medicine
  • biomarkers
  • survivorship
  • quality of life

Published Papers

This special issue is now open for submission.
Back to TopTop